Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

× No keyword cloud information.

96 in total

1. Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro.

Authors: B Hellmich; E Csernok; A Trabandt; W L Gross; M Ernst
Journal: Clin Exp Immunol Date: 2000-05 Impact factor: 4.330

2. Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy.

Authors: Yoshihiro Yakushijin; Hisaharu Shikata; Ikue Takaoka; Tamami Horikawa; Kazuhito Takeuchi; Jun Yamanouchi; Taichi Azuma; Hiroshi Narumi; Takaaki Hato; Masaki Yasukawa
Journal: Int J Clin Oncol Date: 2010-10-06 Impact factor: 3.402

3. Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.

Authors: R Badaró; C Nascimento; J S Carvalho; F Badaró; D Russo; J L Ho; S G Reed; W D Johnson; T C Jones
Journal: Eur J Clin Microbiol Infect Dis Date: 1994 Impact factor: 3.267

4. Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.

Authors: Hisaharu Shikata; Yoshihiro Yakushijin; Jun Yamanouchi; Taichi Azuma; Masaki Yasukawa
Journal: Int J Clin Oncol Date: 2013-02-05 Impact factor: 3.402

5. Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors: Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal: Ann Surg Date: 2004-01 Impact factor: 12.969

Review 6. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.

Authors: Der-Cherng Liang
Journal: Paediatr Drugs Date: 2003 Impact factor: 3.022

7. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils.

Authors: M J Coffey; S M Phare; S George; M Peters-Golden; P H Kazanjian
Journal: J Clin Invest Date: 1998-08-15 Impact factor: 14.808

8. Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.

Authors: T Lazard; C Perronne; Y Cohen; J Grosset; J L Vilde; J J Pocidalo
Journal: Antimicrob Agents Chemother Date: 1993-04 Impact factor: 5.191

9. Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF).

Authors: A Willfort; C Lorber; S Kapiotis; S Sertl; R Hainz; P Kirchweger; U Jäger; P A Kyrle; K Lechner; K Geissler
Journal: Ann Hematol Date: 1993-05 Impact factor: 3.673

10. Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis.

Authors: C Azcona; V Alzina; P Barona; L Sierrasesúmaga; I Villa-Elízaga
Journal: Eur J Pediatr Date: 1994-03 Impact factor: 3.183